NCT05400057 is a clinical trial in Oral Lichen Planus, sponsored by Moataz Mahmoud.

Who is sponsoring NCT05400057?

NCT05400057 is sponsored by Moataz Mahmoud.

What condition does NCT05400057 study?

NCT05400057 studies Oral Lichen Planus, Oral Cancer.

Is NCT05400057 still recruiting?

NCT05400057 is currently completed. Last updated 10 October 2023.

Last reviewed 2023-10-10 · How we verify

NCT05400057

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

the Oncogenic Potential of Salivary miRNA-93 and miRNA-412-3P in Oral Lichen Planus Patients

Completed Last updated 10 October 2023

What this trial tests

trial in Oral Lichen Planus in 60 participants. Completed in 30 September 2023.

Timeline

15 January 2023

Primary endpoint
20 September 2023

30 September 2023

Quick facts

Lead sponsor	Moataz Mahmoud
Status	Completed
Study type	OBSERVATIONAL
Enrollment	60
Start date	15 January 2023
Primary completion	20 September 2023
Estimated completion	30 September 2023
Sites	2 locations across Egypt

Conditions studied

Oral Lichen Planus — all drugs for Oral Lichen Planus →
Oral Cancer — all drugs for Oral Cancer →

Sponsor

Moataz Mahmoud

Who can join

Adults 40 to 70, any sex, with Oral Lichen Planus or Oral Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Assessment The oncogenic potential of salivary microRNA-93 and microRNA-412-3p in oral lichen planus

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Non-coding RNAs as therapeutic targets in cancer and its clinical application.
Leng X, Zhang M, Xu Y, Wang J, et al · · 2024 · cited 20× · PMID 39149142 · DOI 10.1016/j.jpha.2024.02.001

Verify or expand the search:

Other recruiting trials for Oral Lichen Planus

Currently open trials in the same condition.

NCT06981767 — Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Oral Lichen Planus · Phase 2 · recruiting
NCT07131813 — Evaluation of Efficacy and Safety of add-on Tofacitinib in Patients With Oral Lichen Planus · Phase 4 · recruiting
NCT06932848 — The Therapeutic Effect of Curcumin in Nanogels Compared to 0.1% FAO in the Management of Oral Lichen Planus · NA · recruiting
NCT07100613 — Mucoadhesive Modified-Release Formulations for the Topical Treatment of Symptomatic Oral Lichen Planus · Phase 2 · recruiting
NCT06233591 — Evaluating LP-10 in Subjects With OLP · Phase 2 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05400057 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Moataz Mahmoud
Last refreshed: 10 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05400057.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing